John Brooks
SlowingNamed in filings at .406 Ventures
- Board seats filed
- 11
all filings on record
Named in filings at .406 Ventures
all filings on record
last 24 months
from a verified or cited source
| Sernova Biotherapeutics | Medical devices | October 2025 | None on file |
| Alertgy | Medical devices | December 2023 | None on file |
| Theromics | Medical devices | April 2023 | Venture Investors Health |
| iSpecimen | Healthcare services | December 2021 | None on file |
| HEMOSHEAR THERAPEUTICS | Biotech & pharma | February 2021 | None on file |
| AltrixBio | Biotech & pharma | March 2019 | None on file |
| Ammonett Pharma | Biotech & pharma | July 2018 | None on file |
| THERMALIN | Biotech & pharma | July 2017 | None on file |
| HYGIEIA | Digital health | January 2017 | None on file |
| HEMOSHEAR THERAPEUTICS | Not yet classified | October 2013 | None on file |
| Thermalin Diabetes | Biotech & pharma | June 2013 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The category is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Categories of companies where filings name John Brooks on the board, based on 10 filed seats with a verified or cited source.
1 more filed seat not yet classified, left out of the shares above.